Sabrina G Fabi
Sabrina G Fabi is an expert in Dermatology at University of California San Diego Medical Center (United States). As of October 2026, ScienceLeadR ranks Sabrina G Fabi in the top 1% of experts worldwide for Cellulite. Sabrina G Fabi has authored 263 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 895 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Plastic And Esthetic Surgery - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2009 - 2026
Number : 263
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A Randomized, No-Treatment-Controlled Study to Evaluate Effectiveness and Safety of SB-NASHA Injectable Gel for Décolletage Wrinkle Correction. PMID 42847981 — skin, safety, therapeutics | Dermatol Surg | 2026 | 0 |
| Perimenopause and Menopause: The Dermatologist's Role. PMID 42615834 — perimenopause, menopause | Dermatol Surg | 2026 | 0 |
| Perimenopausal Nuances in the Aging Face: A Comprehensive Perspective. PMID 42614013 — aging, menopause | Facial Plast Surg Aesthet Med | 2026 | 0 |
| Neuromodulator-Assisted Tension Reduction in Refractory Bilateral Mandibular Hypertrophic Scars. PMID 42458873 — cicatrix, cicatrix, hypertrophic | Dermatol Surg | 2026 | 0 |
| Patient Misconceptions About Hyaluronic Acid Fillers: Experience-based Considerations. PMID 42427243 — hyaluronic acid, therapeutics | Aesthet Surg J | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT NCT05171894 — photochemotherapy, safety, methyl green, multiple chronic conditions, therapeutics, port-wine stain, pharmaceutical vehicles, nevus, wine | Phase 2 | Recruiting | 2024 |
LeadR Networks
Main global connection map